ELLINGTON MANAGEMENT GROUP LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 91 filers reported holding TG THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$307,000
+51.2%
21,600
-12.6%
0.02%
-33.3%
Q4 2017$203,000
+48.2%
24,700
-16.3%
0.03%
+57.1%
Q4 2016$137,000
+57.5%
29,500
+106.3%
0.02%
-82.6%
Q2 2016$87,000
-47.3%
14,300
-26.3%
0.12%
+70.4%
Q1 2016$165,000
+34.1%
19,400
+87.5%
0.07%
+65.1%
Q4 2015$123,000
-77.7%
10,349
-68.8%
0.04%
-68.1%
Q2 2015$551,00033,2000.14%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders